HCA Holdings Inc. diskutieren
HCA Holdings Inc.
WKN: A1JFMW / Symbol: HCA / Name: HCA Holdings / Aktie / Anbieter & Dienstleistungen / Large Cap /
309,80 €
1,21 %
HCA Healthcare, Inc. (NYSE: HCA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $283.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $283.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $315.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $315.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Raymond James from $320.00 to $280.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Stephens from $300.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Citigroup Inc. from $324.00 to $279.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Mizuho from $325.00 to $275.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Royal Bank of Canada from $315.00 to $284.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Truist Financial Co. from $340.00 to $300.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $329.00 to $281.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $315.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $315.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Raymond James from $280.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Raymond James from $300.00 to $330.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Royal Bank of Canada from $308.00 to $322.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Truist Financial Co. from $320.00 to $345.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $335.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $335.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $330.00 to $359.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
Neueste Beiträge
Bank_of_America_Co_ in Seagate Technology.Holdings plc diskutieren